Metadata
- Name
- A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT04632056
- Description
- This study is a prospective, uncontrolled, central registration system, multicenter, domestic
observational study (special drug-use surveillance) to evaluate the safety of 52-week
clinical treatment with Beovu kit for intravitreal injection in nAMD patients. - Data or Study Types
- clinical trial
- Keywords
- CNV, nAMD, Japan, subfoveal choroidal neovascularization, neovascular age-related macular degeneration
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2020
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT04632056
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04632056